ArticleMolecular cancer therapeutics2010

Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.

Suman Kundu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.